Sanofi Consumer Healthcare Complete Financial Statements
SANOFICONR • Review detailed financials to uncover trends, confirm thesis & journal trades
2 Years of Data
2024 - 2023
Complete Financial Data Export
Export complete financial statements for Sanofi Consumer Healthcare (SANOFICONR).
Downloads include all available records across all periods.
Profitability Ratios
Net Profit Margin
24.53%
2024 data
EBITDA Margin
38.48%
2024 data
Operating Margin
37.00%
2024 data
Return on Assets
42.00%
2024 data
Return on Equity
66.30%
2024 data
Balance Sheet Ratios
Current Ratio
14.00
2024 data
Equity Ratio
63.34%
2024 data
Asset Turnover
1.71
2024 data
Year-over-Year Growth Analysis
Comparing March 2024 vs Period
Revenue Growth
+22.4%
Year-over-Year
Net Profit Growth
+32.6%
Year-over-Year
EBITDA Growth
+17.6%
Year-over-Year
Expense Growth
+25.3%
Year-over-Year
Assets Growth
+24.9%
Year-over-Year
Equity Growth
+31.3%
Year-over-Year
Financing Cash Flow Growth
-5900.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2024 | March 2023 |
|---|---|---|---|
| Revenue | 903 | 738 | 560 |
| Expenses | 569 | 454 | 337 |
| EBITDA | 334 | 284 | 223 |
| Operating Profit Margin % | 35.00% | 37.00% | 39.00% |
| Depreciation | 12 | 5 | 2 |
| Interest | 2 | 4 | 0 |
| Profit Before Tax | 320 | 247 | 219 |
| Tax | 82 | 66 | 54 |
| Net Profit | 240 | 181 | 165 |
| Earnings Per Share (₹) | 104.20 | 78.59 | 71.60 |
Related Pages for Sanofi Consumer Healthcare
Additional stock information and data for SANOFICONR
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2024 | 2023 |
|---|---|---|
| ASSETS | ||
| Total Assets | 431 | 345 |
| Current Assets | 392 | 335 |
| Fixed Assets | 29 | 5 |
| Capital Work in Progress | 1 | 3 |
| Investments | 0 | 0 |
| Other Assets | 402 | 338 |
| LIABILITIES | ||
| Total Liabilities | ||
| Current Liabilities | 28 | 8 |
| Non-Current Liabilities | ||
| SHAREHOLDERS' EQUITY | ||
| Total Equity | 273 | 208 |
| Share Capital | 23 | 2 |
| Reserves & Surplus | 250 | 183 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2024 | March 2023 |
|---|---|---|
| Operating Activities | 439 | 0 |
| Investing Activities | 2 | 0 |
| Financing Activities | -116 | 2 |
| Net Cash Flow | 325 | 2 |